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Abstract
The decline in immune function with aging, known as immunosenescence, has been implicated in evolutionarily diverse species,
but the underlying molecular mechanisms are not understood. During aging in Caenorhabditis elegans, intestinal tissue
deterioration and the increased intestinal proliferation of bacteria are observed, but how innate immunity changes during C.
elegans aging has not been defined. Here we show that C. elegans exhibits increased susceptibility to bacterial infection with age,
and we establish that aging is associated with a decline in the activity of the conserved PMK-1 p38 mitogen-activated protein
kinase pathway, which regulates innate immunity in C. elegans. Our data define the phenomenon of innate immunosenescence
in C. elegans in terms of the age-dependent dynamics of the PMK-1 innate immune signaling pathway, and they suggest that a
cycle of intestinal tissue aging, immunosenescence, and bacterial proliferation leads to death in aging C. elegans.
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Introduction
Aging is associated with increased mortality from infection in
evolutionarily diverse species [1]. These observations have been
attributed in part to an age-associated decline in immune function,
termed immunosenescence. In vertebrates, a marked decrease in
T cell receptor diversity associated with thymic involution during
aging is a major contributor to the immunosenescence of the
adaptive immune system [2]. Age-related changes of the innate
immune system and their influence on susceptibility to infectious
diseases are less well understood. Dysfunction of innate immune
function later in life is associated with ‘‘inflammo-aging,’’ a
phenomenon in which an aberrant increase in the production of
pro-inflammatory cytokines can contribute to tissue damage [3].
Such dysregulation may promote disease, as suggested in a recent
report indicating that increased inflammatory signaling through
Toll Like Receptor 3 contributes to increased pathology in West
Nile Virus infection in the elderly [4]. Changes in the amplitude of
immune signaling activity during aging have also been observed in
invertebrates. For example, in aging Drosophila basal immune
signaling is constitutively increased, yet immune responses induced
by bacteria appear to be attenuated [5], and older flies are more
susceptible to infection [6].
Studies of aging in Caenorhabditis elegans have revealed several
biomarkers associated with aging, including increased intestinal
proliferation of the relatively non-pathogenic Escherichia coli strains
that are used as food sources during assays of animal longevity. Intact
bacterial cells are rarely detected within the intestinal lumen of
younger animals, but ultrastructural analysis of aging C. elegans has
revealed discrete areas of bacterial packing and local catastrophic
plasma membrane disruption events, along with extensive deterio-
ration of intestinal tissues [7,8]. There is evidence to suggest that the
accumulation of E. coli within the intestinal lumen during aging is a
cause of death in older animals because C. elegans propagated on killed
or non-dividing E. coli live longer than animals propagated on live E.
coli [7,9]. These data suggest that bacterial pathogenesis is a major
contributor to aging andmortality in C. elegans and raise the possibility
of an age-dependent decline in immune function during aging.
Innate immunity in C. elegans is regulated by a conserved PMK-1
p38 mitogen-activated protein kinase (MAPK) pathway [10] that is
required for resistance to a diverse range of pathogenic bacteria and
fungi [10,11]. PMK-1 regulates the transcription factor ATF-7,
which activates intestinal expression of genes encoding proteins that
contribute to host defense such as C-type lectins, lysozymes, and
putative antimicrobial peptides [12–14]. While PMK-1 is critical for
immune protection during larval development and early adulthood,
its role in innate immunity during aging has not yet been investigated.
In this paper, we report the results of genetic, gene expression
profiling, and biochemical studies during aging in C. elegans which
together demonstrate a marked decline in PMK-1 later in life. We
suggest a model that involves a cycle of immunosenescence, increased
bacterial infection and proliferation, and progressive intestinal tissue
deterioration that accelerates mortality in aging C. elegans.
Results
C. elegans resistance to bacterial infection declines with
advancing age
We began our study of the dynamics of innate immunity during
aging by investigating the age-dependent variation in susceptibility
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of the C. elegans laboratory wild type strain N2 to Pseudomonas
aeruginosa PA14, a human opportunistic pathogen that also kills C.
elegans by an infection-like process in the intestine [15]. The
lifespan of C. elegans wild type strain N2 propagated on the
relatively non-pathogenic bacterial strain E. coli OP50 is
approximately 21 days (Figure 1A). To determine how aging
influences the susceptibility of C. elegans to infection, we challenged
C. elegans with P. aeruginosa at the L4 larval stage (1 day pre-
adulthood), and at Day 3, Day 6, and Day 9 of adulthood by
transferring them from standard plates seeded with E. coli OP50 to
plates seeded with P. aeruginosa PA14 (Figure 1B). Pathogen
susceptibility was not assayed beyond this period because mortality
begins to be observed after Day 12 of adulthood in C. elegans
propagated on E. coli OP50 (Figure 1A). We observed a decline in
the survival time of C. elegans adults transferred to P. aeruginosa with
advancing age (Figure 2A). Our data are consistent with prior
observations that aging C. elegans have diminished survival upon
challenge with pathogenic bacteria [15–17] and establish that C.
elegans exhibit a progressive age-dependent increase in susceptibil-
ity to infection.
The age-dependent increase in susceptibility of C. elegans to killing
by P. aeruginosa suggests older animals have diminished protective
responses to pathogenic bacteria, which may manifest as an
accelerated accumulation of bacteria during infection. To test this
possibility, L4 larval stage animals and Day 3, 6, and 9 adults were
challenged with a strain of P. aeruginosa which expresses GFP. After
exposure to GFP-expressing P. aeruginosa PA14, C. elegans were scored
for the degree of bacterial accumulation within the intestinal lumen.
We found that one day after an infection was initiated, over half of
Day 9 adultC. elegans accumulate P. aeruginosawithin at least a portion
of their intestine, and that the intestine of some worms is completely
filled with bacteria (Figure 2B). After the same duration of exposure
to P. aeruginosa, 30% of Day 6 adults and less than 10% of Day 3
adults had accumulated detectable levels of GFP-expressing P.
aeruginosa in their intestines. The rate of accumulation of P. aeruginosa
within the intestine increases in an age-dependent manner and
parallels the increased susceptibility to infection (Figure 2A),
suggestive of a decline in immune function during aging.
A decline in PMK-1 activity with intestinal tissue aging
We sought to identify the genetic determinants underlying the
phenomenon of increasing susceptibility to infection with advanc-
ing age. Previously, microarray-based gene expression studies of
aging C. elegans revealed numerous changes in gene expression
during the aging process [18,19]. Upon comparing these data with
our previously reported microarray-based identification of PMK-1
p38 MAPK pathway transcriptional targets [13], we observed an
enrichment for genes regulated by the PMK-1 p38 MAPK
pathway among genes downregulated with aging. To explore this
observation further and to identify genes downregulated during
mid-to-late adulthood, we carried out a full-genome microarray
analysis of aging C. elegans, analyzing gene expression levels in
synchronized populations of N2 worms at Day 6 of adulthood and
Day 15 of adulthood (Figure 3A). We found that when compared
with expression levels at Day 6 of adulthood, approximately 12%
of genes in the C. elegans genome (2535 genes) are downregulated
by 2-fold or more by Day 15 (Figure 3A and Table 1). From this
set of genes, we identified 379 that were downregulated by 10-fold
or greater in Day 15 adults compared to expression levels in Day 6
adults (Table S1). To determine whether this subset of genes
included those which are important for conferring resistance to
infection, we asked if genes previously shown to be upregulated
during an infection in young adult C. elegans were in our list and
found a 7-fold enrichment (p=1.2610221) for genes induced by P.
aeruginosa infection [13]. Moreover, several significant Gene
Ontology (GO) terms associated with genes induced by pathogen
exposure [14,20,21] were found among the genes that are most
Figure 1. Systematic analysis of the survival of aging C. elegans
upon challenge with pathogenic bacteria. (A) Survival of wild type
strain N2 maintained on E. coli OP50 plotted as fraction of worms alive
versus time. Arrows indicate ages of worms when P. aeruginosa
infection was initiated, when reporter gene expression was examined,
and/or when total RNA was harvested for microarray analysis.
(B) Schematic of P. aeruginosa infection assay. At the indicated ages,
subsets of worms from a synchronized population cultured on a lawn of
E. coli OP50 were transferred to plates containing a lawn of
P. aeruginosa PA14, and their survival was monitored twice daily
thereafter.
doi:10.1371/journal.pgen.1002082.g001
Author Summary
Aging is associated with a diminished capacity to resist
infection in evolutionarily diverse species including hu-
mans, mice, and fruit flies. Few studies have addressed the
underlying genetic and molecular basis of this phenom-
enon. Here we examined immune function during aging in
the nematode Caenorhabditis elegans, which we demon-
strate exhibits a progressive age-dependent increase in
susceptibility to the human pathogen Pseudomonas
aeruginosa. Our studies suggest that, during aging in C.
elegans, the activity of the PMK-1 p38 mitogen-activated
protein kinase pathway, a conserved pathway involved in
pathogen defense, sharply declines. We propose a model
in which age-related damage to intestinal tissue impairs
immune function and therefore promotes infection, which
in turn amplifies tissue damage, thus setting in motion a
self-perpetuating cycle that gradually erodes host defense.
Immunosenescence in C. elegans
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downregulated during mid-to-late adulthood, including ‘‘peptidase
activity,’’ ‘‘hydrolase activity,’’ and ‘‘lipid metabolic activity’’
(Table S2).
GO analysis of genes downregulated between Days 6 and 15 of
adulthood in C. elegans revealed an enrichment for some of the
same GO terms associated with the transcriptional targets of both
PMK-1 and DAF-16, a conserved FOXO transcription factor
that, in the absence of inhibition through the insulin signaling
pathway, upregulates the expression of genes involved in lifespan
determination, stress response, and innate immunity [13,22,23]
(Table S2). We examined the expression levels of downstream
targets of PMK-1 and DAF-16 among genes that are downreg-
ulated during aging. When mapped onto a scatter plot comparing
gene expression in Day 15 adult C. elegans to expression levels in
Day 6 adults, almost all PMK-1 targets show sharp downregula-
tion (Figure 3A). DAF-16 targets, however, exhibit a pattern that is
more representative of the genome-wide changes in expression
that occur during aging. Specifically, while the expression levels of
many DAF-16 targets either remain unchanged or decrease, other
target genes appear to be upregulated during mid- to late
adulthood, suggesting that DAF-16 remains active later in life, in
contrast to the apparent age-dependent decline in PMK-1 activity
(Figure S1).
Of the genes that are downregulated by at least 2-fold in older
adult animals, 42 have previously been shown to be regulated by
the PMK-1 p38 MAPK pathway [13]. A total of 26 of these PMK-
1 transcriptional targets are among the 379 genes that are sharply
downregulated late in aging, which represents a dramatic and
significant 24-fold enrichment (p=8.7610230) for PMK-1-regu-
lated genes among genes exhibiting markedly decreased expres-
sion levels between Day 6 and Day 15 of adulthood. This
enrichment is particularly evident when highlighting PMK-1-
regulated genes on a scatter plot of expression levels of Day 15
versus Day 6 adults (Figure 3A). Quantitation of endogenous
transcript levels of two PMK-1 targets in wild type C. elegans during
mid- to late adulthood by qRT-PCR confirmed that a gradual
decline in the expression of PMK-1-regulated genes indeed occurs
between Day 6 and Day 15 of adulthood and is most pronounced
after Day 9 (Figure 3B). Furthermore, this analysis corroborated
the magnitudes of the changes that were measured by microarray-
based expression profiling. Supporting these measurements of
endogenous PMK-1 target transcript levels, we also observed
diminished expression of the agIs219 reporter transgene, which
consists of the promoter for a transcriptional target of PMK-1,
T24B8.5, fused to GFP [12], in the intestinal cells of older adult C.
elegans (Figure 3C). In sum, these studies indicate a striking age-
dependent decline in the expression of PMK-1 transcriptional
targets.
Electron microscopy of aging C. elegans has revealed dramatic
deterioration of multiple tissues, including the intestine, with
advancing age [8]. We anticipated that tissue deterioration would
result in the global attenuation of the expression of intestinal genes
in older adult animals. We compared the gene expression profile
for genes differentially expressed at Day 15 versus Day 6 of
adulthood with genes previously defined as being expressed in the
C. elegans intestine [24,25]. Consistent with the possibility that
tissue deterioration causes a global decline in intestinal cell
transcription toward the end of life, we found that over 40% of
intestine-expressed genes (305/659) are among the genes that are
downregulated by at least 2-fold late in aging (Figure 3A and
Table 1). A total of 60 of these genes were among the 379 genes
with a 10-fold or greater decrease in expression in Day 15 adults
compared to Day 6 animals (Figure 3A and Table 1). This is
greater than the number of intestine-expressed genes expected to
be found by chance and represents a 5-fold enrichment
(p=2.0610224) for intestine-expressed genes among those that
are the most downregulated in older adult animals.
The sharp decline in the expression of transcriptional targets of
the PMK-1 pathway with advancing age, even relative to the age-
related decrease in intestinal gene expression, suggests that the
activity of the PMK-1 pathway fades in late adulthood in C. elegans.
We asked whether pmk-1 itself might be regulated at either the
level of mRNA, protein, or phosphorylation during aging. By
qRT-PCR analysis, we observed that compared to expression
levels at the L4 larval stage, pmk-1 expression showed a relatively
modest decline of no more than two-fold in 12- and 15-day-old
worms, far less than the degree to which PMK-1 transcriptional
target expression was reduced during aging (Figure 3D). In
contrast, the levels of PMK-1 protein showed a marked decline
starting around Day 9 of adulthood, to the point where by Day 15,
,16% of the levels of PMK-1 observed in late larval stage animals
remained (Figure 4). Using an antibody that specifically recognizes
the doubly phosphorylated activated form of PMK-1, we found a
corresponding age-dependent decrease in the levels of activated
PMK-1 during aging. Our studies of pmk-1 transcript and protein
Figure 2. Increased susceptibility of C. elegans to lethal
infection with aging. (A) Survival of wild type strain N2 transferred
from E. coli OP50 to P. aeruginosa PA14 at L4 (orange), Day 3 (magenta),
Day 6 (blue), or Day 9 (green) plotted as fraction of worms alive versus
time. (B) Accumulation of P. aeruginosa within the intestinal lumen of C.
elegans at,24 h post-infection. Wild type N2 strain late larval stage (L4)
and adult worms were infected with a strain of P. aeruginosa that
expresses GFP and then scored the next day according to the extent of
bacterial colonization of the intestine. The pattern of P. aeruginosa
infection in individual animals was classified as either ‘‘None’’ when no
GFP-expressing P. aeruginosa could be detected in the intestine,
‘‘Partial’’ when P. aeruginosa colonization of the intestine was
incomplete or was localized to a bolus, or ‘‘Full’’ when the intestinal
lumen was completely packed with bacteria along its entire length.
doi:10.1371/journal.pgen.1002082.g002
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levels during aging suggest that diminishing PMK-1 protein
abundance is responsible for the attenuated activity of the PMK-1
signaling pathway later in life.
Previously, we established that mutations that attenuate the
activity of the PMK-1 pathway result in enhanced susceptibility to
killing by P. aeruginosa during larval development and young
adulthood [10]. The striking decrease in expression of PMK-1-
regulated genes and the observed decline in PMK-1 levels in aging
animals suggested a diminished role for the PMK-1 pathway in
host defense towards the end of life. Consistent with this
prediction, we observed that with advancing age, the difference
in survival between wild type and pmk-1 mutants challenged with
Figure 3. A decline in expression of PMK-1 transcriptional targets during aging in the C. elegans intestine. (A) Scatter plots comparing
gene expression levels in the C. elegans wild type N2 strain at Day 15 versus Day 6 of adulthood. Each dot represents an individual gene; brown, all
genes on the full-genome microarray; blue, genes previously shown to exhibit enriched expression levels in the C. elegans intestine; red, genes
previously identified as being regulated by the PMK-1 pathway. Genes on the solid diagonal line are expressed at equivalent levels at both time
points. Genes below the dashed diagonal line are downregulated by more than 10-fold between Day 6 and Day 15 of adulthood. (B) qRT-PCR of
endogenous C17H12.8 and T24B8.5 mRNA levels during aging relative to expression at Day 3 of adulthood. The average of three experiments using
independent biological replicates of total RNA for cDNA synthesis is shown. Bars indicate standard deviation. (C) Fluorescence microscopy of C.
elegans carrying the agIs219 transgene, a GFP reporter of PMK-1 activity, at the indicated ages. (D) qRT-PCR of pmk-1 transcript levels during aging
relative to expression at L4. The average of two experiments using independent biological replicates of total RNA for cDNA synthesis is shown.
doi:10.1371/journal.pgen.1002082.g003
Table 1. Distribution of intestine-enriched genes and PMK-1 transcriptional targets among genes downregulated at Day 15 versus
Day 6 of adulthood.
Day 15/Day 6 Expression Level
Genes Number of Genes $2-fold Decrease $10-fold Decrease p-value
Whole genome ,20,000 2535/20,000 379/20,000
Intestine-enriched 659 305/659 60/659 2.0610224
PMK-1 targets 58 42/58 26/58 8.7610230
The number of intestine-expressed genes (based on a list compiled from previous studies [24,25]) and PMK-1 transcriptional targets (identified previously [13]) with
levels of expression reduced by either$2-fold or$10-fold in Day 15 animals compared to expression levels in Day 6 adults is reported. The statistical significance of the
fold difference among genes downregulated by 10-fold or more between Day 6 and Day 15 of adulthood is represented by a hypergeometric p-value.
doi:10.1371/journal.pgen.1002082.t001
Immunosenescence in C. elegans
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P. aeruginosa subsides (Figure 5A–5D). Whereas pmk-1 loss of
function shortens the LT50 (median time to death) of 3- and 6-day-
old adult C. elegans challenged with P. aeruginosa by 50% and ,60%
respectively, when infection is initiated at Day 9 of adulthood, wild
type animals and pmk-1 mutants die at an equivalent rate.
Considering the decrease in abundance of the active, phos-
phorylated form of PMK-1 during aging (Figure 4) we tested
whether inactivating VHP-1, a phosphatase which negatively
regulates PMK-1 during larval development in C. elegans [26],
could rescue the enhanced susceptibility of older adult animals to
infection.
We reasoned that reduced VHP-1 function might prevent or
delay the decrease in PMK-1 activity that occurs during aging.
RNAi-mediated knock-down of vhp-1 during adulthood failed to
improve the resistance of Day 9 adults to P. aeruginosa infection
(Figure S2). These data provide further evidence to suggest that
the age-dependent decline in PMK-1 activity later in life results
from the waning abundance of PMK-1 protein and not from a
decrease in PMK-1 phosphorylation.
PMK-1 mediates host defense in C. elegans by regulating the
expression of genes encoding proteins important for the response
to infection [13,14]. In earlier studies, we found that RNAi of
individual transcriptional targets of the PMK-1 pathway did not
yield a pathogen susceptibility phenotype, indicative of functional
redundancy among putative immune effectors regulated by PMK-
1 [13]. We repeated this analysis in older C. elegans, carrying out
the inactivation of 29 individual PMK-1 targets by RNAi to
determine if we could phenocopy the susceptibility phenotype of
Day 6 pmk-1 mutants upon infection with P. aeruginosa (Figure S3,
Figure S4). Included among these genes were several found to be
upregulated in response to P. aeruginosa infection [13]. For 27 of 29
targets, RNAi-mediated gene inactivationn produced no repro-
ducible effect on pathogen susceptibility. A modest effect on
pathogen susceptibility was observed upon RNAi of nlp-31
(B0213.6) and tag-38 (B0222.4), but the small effects suggest that
downstream targets of PMK-1 primarily function redundantly to
mediate innate immunity in aging C. elegans, as was observed for
young adult C. elegans [13].
The standard laboratory food source for C. elegans, E. coli OP50,
is likely pathogenic to aging animals [7,9,27]. Therefore, if the role
of PMK-1 in host defense is to protect against infection, then the
effects of exposure to E. coli that mimic an infection should be
enhanced by the progressive decline in PMK-1 activity during
aging. Intestinal distention due to bacterial packing develops in
aging adults [7], with ultrastructural evidence that this accumu-
lation of bacteria can contribute to death [8]. Consistent with the
role of PMK-1 in innate immunity, we observed that the pmk-1
mutant exhibited increased accumulation of E. coli with aging
relative to wild-type C. elegans (Figure 6A). As assessed by intestinal
distention, we observed a 5-fold greater prevalence of E. coli
accumulation within the intestine of pmk-1 mutants as compared to
wild type C. elegans at Day 6 of adulthood. Whereas the
Figure 4. A gradual reduction in the levels of total and
activated PMK-1 protein throughout adulthood in C. elegans.
Immunoblot analysis of total and activated PMK-1 during aging. Total
protein isolated from L4 larval stage pmk-1(km25) (lane 1), L4 sek-1(km4)
(lane 2) or L4 and adult wild type N2 strain (lanes 3-8) was separated by
SDS-PAGE, and immunoblots were decorated with antibodies to either
PMK-1 (Total PMK-1), phosphorylated PMK-1 (Active PMK-1) or b-tubulin
(Tubulin).
doi:10.1371/journal.pgen.1002082.g004
Figure 5. Age-dependent decrease in the contribution of PMK-1
p38 MAPK signaling to C. elegans immunity. (A) Survival of wild type
strain N2 (orange) and the pmk-1(km25) mutant (blue) transferred from
E. coliOP50 to P. aeruginosa PA14 at L4, and at Days 3, 6, and 9 of adulthood
(B–D, respectively), plotted as fraction of worms alive versus time.
doi:10.1371/journal.pgen.1002082.g005
Immunosenescence in C. elegans
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accumulation of E. coli increased in an age-dependent manner, we
observed that the difference between wild type and pmk-1 mutant
C. elegans diminished with advancing age (Figure 6A). By Day 9
and Day 12 of adulthood, twice as many pmk-1 mutants exhibited
a distended intestinal lumen as compared to age-matched wild
type animals, in contrast to the 5-fold difference observed at Day 6
of adulthood. These data corroborate our observations that the
contribution of PMK-1 to host defense declines in an age-
dependent manner during adulthood.
Discussion
Immunosenescence in C. elegans
Although a number of observations in diverse species suggest
dysfunction of the innate immune system with aging, how innate
immunity changes over the course of the aging process has been
unclear. Our data suggest that the diminishing contribution of the
PMK-1 pathway to resistance to P. aeruginosa infection in aging
animals underlies the increasing susceptibility to infection of C.
elegans with advancing age. The global decline in intestinal gene
expression with advancing age is consistent with ultrastructural
observations that show a deterioration of intestinal cells with aging.
Because the intestinal cells are the principal cells of host defense in
C. elegans, functioning as a mucosal defense barrier, tissue aging
may compromise the ability of these cells to function in resistance
to infection. Thus, we hypothesize that the aging of intestinal cells
may contribute to immunosenescence which, in turn, as we discuss
below, may promote the aging process.
A cycle of intestinal tissue aging, immunosenescence,
and bacterial infection promotes aging and mortality in
C. elegans
While the activity of the genetic determinants of aging appears
to be coordinated among the various tissue types in C. elegans [28–
31], different tissues exhibit distinct degrees of deterioration with
advancing age. For example, whereas neurons exhibit minimal
evidence of age-related damage in C. elegans, intestinal cells exhibit
morphological changes during aging, including areas of plasma
membrane disruption and the disappearance of microvilli [8].
Stochastic localized aging has also been reported in murine models
where mucosal immunity in the gastrointestinal tract may exhibit
early aging relative to components of systemic immunity such as
the spleen [32]. Unlike the intestinal cells of vertebrates, intestinal
cells of C. elegans are post-mitotic, and thus bacteria present in the
intestinal lumen may accelerate tissue aging during the infection
process through the secretion of toxins and other virulence
mechanisms. Therefore, investigating the interaction between
older adult C. elegans and pathogenic bacteria that infect the gut
provides a system for understanding the chronic effects of aging on
immune function and, in a reciprocal manner, the contribution of
innate immunity to tissue aging.
The proliferation of bacteria in the intestinal lumen of aging C.
elegans suggests two opposing hypotheses regarding innate immune
function. One possibility is that increased bacterial packing and
proliferation might lead to the pathological activation of innate
immune responses that may directly contribute to host lethality.
Derangement and hyperactivation of innate immunity is observed
in septic shock during overwhelming infection in humans [33]. In
this scenario the sustained, excessive activity of the immune system
could result in collateral tissue damage that exacerbates age-
related deterioration. Indeed, we recently characterized how the
innate immune response itself can be lethal during C. elegans
development in the absence of homeostatic endoplasmic reticulum
stress responses [34]. However, we found no evidence of increased
immune function in older adult C. elegans. Instead our data suggest
an alternative situation in which innate immune function declines
during aging, likely contributing to progressive bacterial prolifer-
ation. Infection has been hypothesized to be a major cause of
death in aging worms, based on lifespan extensions conferred by
feeding animals killed instead of live bacteria [7,9] and the
Figure 6. A cycle of intestinal tissue aging, immunosenescence,
and progressive intestinal proliferation of bacteria towards the
end of life in C. elegans. (A) Fraction of wild type N2 C. elegans (white
bars) or pmk-1(km25) mutants (grey bars) maintained on lawns of E. coli
OP50 that exhibit intestinal distention at Days 6, 9, and 12 of adulthood.
Inset, ratio of the average number of pmk-1 mutants with intestinal
distention versus the average number of wild type animals with
intestinal distention at Days 6, 9, or 12 of adulthood. (B) As the primary
immune cells in C. elegans, age-related damage to intestinal cells may
impair their ability to execute processes required for immune
protection, such as the expression of immune effector proteins,
including those regulated by the PMK-1 pathway. The consequent
reduction in host defense would lead to increased colonization of the
C. elegans intestine by pathogenic microbes, which contribute to and
amplify intestinal cell deterioration during the infection process. Thus a
self-perpetuating cycle of increased intestinal deterioration, decreased
immunity, and increased accumulation of bacteria may underlie
immunosenescence and significantly contribute to mortality later in life.
doi:10.1371/journal.pgen.1002082.g006
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aforementioned ultrastructural observations [8]. Because the
intestinal cells function as immune cells in C. elegans, intestinal
tissue deterioration may impair mucosal immune defenses. Taken
together with prior observations of intestinal tissue aging and
bacterial proliferation in aging animals, our data on C. elegans
immunosenescence suggest a downward spiral during aging such
that a decline in immunity promotes the increased proliferation of
bacteria, which in turn, may accelerate intestinal tissue aging and
deterioration (Figure 6B). Ultimately, the senescence of innate
immunity suggests that aging C. elegans lack components of host
defense that confer protection from infection earlier in life,
allowing for the proliferation of even relatively non-pathogenic
bacteria that may substantially contribute to mortality. We
speculate that immunosenescence may herald the transition to
the terminal stages of the aging process in C. elegans.
Materials and Methods
C. elegans growth for aging and lifespan assays
Animals were synchronized by hypochlorite treatment and L1
arrest. Starved L1 larvae were placed onto NGM plates seeded
with E. coli OP50 and grown at 20uC to the L4 stage. L4 animals
were transferred by chunking to 10 cm NGM plates supplemented
with 50 mg/ml 5-fluorordeoxyuridine (FUdR) and seeded with E.
coli OP50. Worms were maintained on these plates at 20uC until
they were used for experiments at Days 3, 6, 9, 12, or 15 of
adulthood. Plates that became contaminated or significantly
depleted of E. coli OP50 over time were discarded.
To determine the lifespan of C. elegans wild type strain N2, worms
were synchronized and grown to L4 as described above and then
picked over to 6 cm E. coli OP50-seeded NGM plates containing
50 mg/ml FUdR at 20uC where they were maintained throughout
the assay. A total of approximately 100 worms were transferred to
three NGM plates (,30 worms/plate) in each replicate assay.
Worms were scored every 2–4 days beginning at Day 7 of adulthood
by gently prodding with a platinum wire to test for touch sensitivity
as an indication of life or death. Lifespan is defined as the time
elapsed from when worms were transferred to FUdR plates (time
= 0 on survival curves) to when they were scored as dead.
Analysis of bacterial accumulation
To analyze bacterial accumulation in the intestinal lumen
during infection with P. aeruginosa, worms were transferred from
plates containing E. coli OP50 to plates containing a strain of P.
aeruginosa PA14 which expresses GFP [15]. Animals were
monitored for the presence of GFP-P. aeruginosa within the
intestinal lumen by fluorescence microscopy ,24 h after initiating
the infection. At the time of scoring, in order to visualize worms in
the absence of interfering GFP signal from the bacterial lawn,
worms were transferred from plates containing GFP-P. aeruginosa to
E. coli OP50 plates. At 4x magnification bacterial accumulation
was scored according to the following criteria: ‘‘none’’ if no GFP
signal could be detected in the intestinal lumen, ‘‘partial’’ if GFP-
P. aeruginosa was observed in only a portion of the intestine or was
dispersedly distributed throughout the intestine, or ‘‘full’’ if a
robust GFP signal could be detected without interruption along
the entire length of the intestinal lumen.
To measure the prevalence of E. coli accumulation within the
intestinal lumen during aging, wild type N2 C. elegans or pmk-1
mutants were maintained on lawns of E. coli OP50 at 20uC as
described above. Beginning at Day 6 and continuing at regular
intervals until Day 12 of adulthood, animals were examined for
evidence of bacterial packing as manifest in intestinal distention.
At each time point, at least 70 worms of each strain were
anaesthetized with 10 mM sodium azide and mounted on glass
slides for examination by Nomarski microscopy. At 100x
magnification animals were scored positive for intestinal distention
if sections of their intestinal lumen appeared to be abnormally
wide and resulted in the apparent compression of the bordering
intestinal cells.
Isolation of RNA for quantitative RT-PCR and microarray
analysis
Synchronized populations of C. elegans were generated as
described above and then harvested at the indicated ages by
rinsing plates with M9 buffer and collecting animals into 15 ml
conical tubes. After allowing worms to settle, the supernatant was
removed and animals were rinsed with fresh M9. Washed worms
were transferred to a screw-capped tube, resuspended in Tri
reagent (Ambion) and vortexed before flash freezing in liquid
nitrogen for storage at 280uC. Following phenol-chloroform
extraction, RNA was precipitated in isopropanol and resuspended
in RNAse-free water. For replicate microarray experiments and
qRT-PCR, RNA was isolated from three populations of N2
worms that were independently propagated.
Quantitative RT-PCR (qRT-PCR) analysis
Total RNA was reverse-transcribed using the Retroscript kit
(Ambion). The resulting cDNA was used as the template in
triplicate qRT-PCR reactions using SYBR Green detection
(Roche) in a Mastercycler Realplex (Eppendorf). Primers for
amplification of T24B8.5 and C17H12.8 were as described in a
previous study [13]. The DDCt method was used determine
relative mRNA levels using expression of tba-1 (primers described
previously [35]) as a normalization control. The abundance of tba-
1 did not change during aging (data not shown) when normalized
to the levels of either nhr-23 (primers described previously [13]) or
act-1 (primers described previously [36]).
RNA hybridization and analysis of microarray chips
RNA was quantified and quality confirmed using an Agilent
2100 Bioanalyzer (Agilent Technologies, Inc.). 100 ng of total
RNA was amplified and labeled using the NuGEN Ovation RNA
amplification v2 kit (NuGEN Technologies, Inc.) according to the
manufacturer’s instructions. Samples were hybridized to Gene-
Chip C. elegans genome microarrays at 45uC for 16 h, and chips
were scanned using an Affymetrix GeneChip Scanner 3000 7G
(Affymetrix Inc.). Absent/present calls were generated by
analyzing the data with Microarray Suite version 5 (MAS5.0).
Processed arrays were normalized and log2 expression values
output using GCRMA [37]. Microarray data have been deposited
in NCBI’s Gene Expression Omnibus and are accessible online
through GEO Series accession number GSE21784 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21784).
Statistical analysis of microarray data
The GCRMA output was filtered such that genes without at
least one present call were eliminated. For the remaining genes,
log2 expression values were normalized by first calculating the
mean of the expression values of all replicates at all time points for
an individual gene and then subtracting the result from every
expression value corresponding to that gene in all of the replicates.
To determine age-dependent changes in gene expression the mean
log ratio of gene expression at two different points during aging
was calculated, and a 2-tailed unpaired Student’s t test was used to
identify genes with statistically significant (p-value #0.05) changes
in expression levels as a function of age.
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Lists of genes with significant changes in expression during aging
were queried for the presence of transcriptional targets of PMK-1 or
for genes with enriched levels of expression in the C. elegans intestine.
PMK-1 targets were identified in a previous study [13] and are
defined as genes upregulated by 2.5-fold or greater in glp-4(bn2)
versus glp-4 (bn2); sek-1(ag1) with a p-value of ,0.05 (t-test). A list of
genes with enriched intestinal expression was compiled by
combining the unique results from SAGE library analysis of
intestinal tissue isolated from adult C. elegans [24] and from
microarray-based studies of intestine-expressed genes in L4 larval
stage animals [25]. In cases where no CDS identifier was available
in the WormBase genome database (http://www.wormbase.org),
the gene was excluded from comparison to our microarray data.
To determine the fold enrichment of PMK-1 target genes,
PA14-induced, or intestine-expressed genes in our data sets, the
fraction of target genes in a given data set (e.g. 26 PMK-1-
regulated genes/379 genes with decreased expression at Day 15
versus Day 6) was divided by the fraction of target genes present in
the C. elegans genome (e.g. 58 total PMK-1 targets/20,000 genes in
the genome). p-values for fold enrichment were determined by
calculating hypergeometric distribution. Significant GO ontology
terms associated with subsets of genes in the microarray
experiments were identified using the web-based application
FatiGO (http://babelomics3.bioinfo.cipf.es/) [38]. Scatter plots
were constructed by plotting average raw transformed intensities
from three independent biological replicates for each gene on the
GeneChip C. elegans genome microarrays using GraphPad Prism
(version 4.0b).
Immunoblot analysis
To prepare total protein lysates for western analysis, worms
were harvested as described above for RNA isolation, except that
after transferring animals to a screw-capped tube, the supernatant
was replaced with 300 ml of SDS Sample Buffer (4% sodium
dodecyl sulfate [SDS], 100 mM Tris?Cl pH 6.8, 20% glycerol).
After boiling worms for 15 min, insoluble material was pelleted by
centrifuging tubes at 10,000 g for 5 min, and the supernatant was
transferred to a new tube which was immediately frozen at 280uC
for storage until further analysis. The amount of total protein
present in the lysates was determined using a BCA Protein Assay
kit (Pierce). To prepare samples for SDS-PAGE, 100 mM
dithiothreitol (DTT) and 0.1% bromphenol blue were added
before boiling for 5 min. Proteins were separated on 10% SDS-
PAGE gels (Bio-Rad) and then transferred to nitrocellulose
membranes (Bio-Rad) according to the manufacturer’s instruc-
tions. For western blotting analysis, membranes were probed with
anti-PMK-1 antibody ([10]; gift of K. Matsumoto), anti-phospho-
p38 (Promega) or anti-b-tubulin (E7, Developmental Studies
Hybridoma Bank, Iowa City, Iowa). Immune complexes were
detected using HRP-conjugated secondary antibodies (GE
Healthcare) followed by chemiluminescence (Amersham ECL
Advance Western Blotting Detection Kit, GE Healthcare).
Western blots were quantitated using ImageJ 1.43u software
(available online at http://rsb.info.nih.gov/ij/download.html).
RNAi of PMK-1 transcriptional targets, vhp-1, and pmk-1
RNAi by bacterial feeding using E. coli HT115 bearing plasmids
corresponding to the transcriptional targets of PMK-1 (obtained
from the Ahringer library [39]), vhp-1 [26] or pmk-1 [26] was carried
out as described [40] with the following modifications. No
tetracycline or isopropyl b-D-1 thiogalactopyranoside (IPTG) was
added to liquid bacterial cultures. RNAi plates contained a final
concentration of 2 mM IPTG to induce expression of RNAi
constructs and were not supplemented with tetracycline. For
experiments involving RNAi treatment of adult animals, 50 mg/
ml FUdR was added to the plates. In experiments involving RNAi
of PMK-1 targets, synchronized C. elegans L1 larvae were added to
RNAi bacteria plates, then transferred to new RNAi plates
containing FUdR once they reached the L4 stage where they were
maintained until challenged with P. aeruginosa at Day 6 of adulthood.
For RNAi of vhp-1, Day 6 adult C. elegans were transferred from E.
coli OP50 to RNAi food where they were maintained until
challenged with P. aeruginosa at Day 9 of adulthood.
Supporting Information
Figure S1 DAF-16 targets are representative of genome-wide
changes in expression during aging in C. elegans. Scatter plot
comparing gene expression levels in the C. elegans wild type N2
strain at Day 15 versus Day 6 of adulthood. Each dot represents an
individual gene; brown, all genes on the full-genome microarray;
red, genes previously identified as being regulated by the DAF-16
pathway [13,22,23]. Genes on the solid diagonal line are expressed
at equivalent levels at both time points.
(TIF)
Figure S2 Inactivation of VHP-1 during adulthood fails to
rescue age-related enhanced susceptibility to pathogen in C. elegans.
Wild type N2 animals were treated with RNAi directed against
vhp-1 (orange), pmk-1 (black) or an empty vector (L4440, blue) from
Day 6 until Day 9 of adulthood. Survival of RNAi-treated animals
transferred to P. aeruginosa PA14 at Day 9 of adulthood is plotted as
fraction of worms alive versus time.
(TIF)
Figure S3 Functional redundancy among PMK-1 transcription-
al targets in C. elegans innate immunity (Replicate 1). (A–G) Wild
type N2 C. elegans were treated with RNAi directed against the
indicated PMK-1 transcriptional targets or with empty vector
L4440 from the L1 stage until Day 6 of adulthood. Survival of
RNAi-treated animals transferred to P. aeruginosa PA14 at Day 6 of
adulthood is plotted as fraction of worms alive versus time. The
results of the first biological replicate are shown.
(TIF)
Figure S4 Functional redundancy among PMK-1 transcription-
al targets in C. elegans innate immunity (Replicate 2). (A–G) Wild
type N2 C. elegans were treated with RNAi directed against the
indicated PMK-1 transcriptional targets or with empty vector
L4440 from the L1 stage until Day 6 of adulthood. Survival of
RNAi-treated animals transferred to P. aeruginosa PA14 at Day 6 of
adulthood is plotted as fraction of worms alive versus time. The
results of the second biological replicate are shown.
(TIF)
Table S1 PMK-1 targets downregulated by 10-fold or more in
Day 15 adults, relative to expression levels in Day 6 adults. List of
PMK-1 targets identified amonggenes with a $10-fold reduction
in expression levels in Day 15 adults compared to Day 6
expression levels (p#0.05).
(XLS)
Table S2 Significant GO terms associated with genes downreg-
ulated by 10-fold or more between Day 6 and Day 15 of adulthood
in C. elegans. List of Gene Ontology (GO) terms describing
biological processes or molecular functions with significant
enrichment (p,0.05) among genes downregulated during aging
in C. elegans. For comparison, significant GO terms (p,0.05)
associated with transcriptional targets of PMK-1 and DAF-16 are
also included.
(XLS)
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